Slow Down The Adaptive Trials Train, FDA Says
This article was originally published in The Pink Sheet Daily
Executive Summary
More definitions are needed to ensure that adaptive clinical trials are "not a fad but an innovation," agency tells PhRMA-sponsored workshop.